Home > Publications database > Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium. > print

001     144029
005     20240229112615.0
024 7 _ |a 10.1093/annonc/mdz138
|2 doi
024 7 _ |a pmid:31185496
|2 pmid
024 7 _ |a 0923-7534
|2 ISSN
024 7 _ |a 1569-8041
|2 ISSN
024 7 _ |a altmetric:61929719
|2 altmetric
037 _ _ |a DKFZ-2019-01580
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Kreimer, A. R.
|b 0
245 _ _ |a Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
260 _ _ |a Oxford
|c 2019
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1677765603_19618
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Ferreiro-Iglesias, A.
|b 1
700 1 _ |a Nygard, M.
|b 2
700 1 _ |a Bender, N.
|0 P:(DE-He78)540833b33724d8def638cce2f0b4e187
|b 3
700 1 _ |a Schroeder, L.
|0 P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb
|b 4
700 1 _ |a Hildesheim, A.
|b 5
700 1 _ |a Robbins, H. A.
|b 6
700 1 _ |a Pawlita, M.
|0 P:(DE-He78)d99bad949ba3ae93859eedae5ac266da
|b 7
700 1 _ |a Langseth, H.
|b 8
700 1 _ |a Schlecht, N. F.
|b 9
700 1 _ |a Tinker, L. F.
|b 10
700 1 _ |a Agalliu, I.
|b 11
700 1 _ |a Smoller, S. W.
|b 12
700 1 _ |a Ness-Jensen, E.
|b 13
700 1 _ |a Hveem, K.
|b 14
700 1 _ |a D'Souza, G.
|b 15
700 1 _ |a Visvanathan, K.
|b 16
700 1 _ |a May, B.
|b 17
700 1 _ |a Ursin, G.
|b 18
700 1 _ |a Weiderpass, E.
|b 19
700 1 _ |a Giles, G. G.
|b 20
700 1 _ |a Milne, R. L.
|b 21
700 1 _ |a Cai, Q.
|b 22
700 1 _ |a Blot, W. J.
|b 23
700 1 _ |a Zheng, W.
|b 24
700 1 _ |a Weinstein, S. J.
|b 25
700 1 _ |a Albanes, D.
|b 26
700 1 _ |a Brenner, N.
|0 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
|b 27
700 1 _ |a Hoffman-Bolton, J.
|b 28
700 1 _ |a Kaaks, R.
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 29
700 1 _ |a Barricarte, A.
|b 30
700 1 _ |a Tjønneland, A.
|b 31
700 1 _ |a Sacerdote, C.
|b 32
700 1 _ |a Trichopoulou, A.
|b 33
700 1 _ |a Vermeulen, R. C. H.
|b 34
700 1 _ |a Huang, W-Y
|b 35
700 1 _ |a Freedman, N. D.
|b 36
700 1 _ |a Brennan, P.
|b 37
700 1 _ |a Waterboer, T.
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 38
|e Last author
700 1 _ |a Johansson, M.
|b 39
773 _ _ |a 10.1093/annonc/mdz138
|g p. mdz138
|0 PERI:(DE-600)2003498-2
|n 8
|p 1335-1343
|t Annals of oncology
|v 30
|y 2019
|x 1569-8041
909 C O |p VDB
|o oai:inrepo02.dkfz.de:144029
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)540833b33724d8def638cce2f0b4e187
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)d99bad949ba3ae93859eedae5ac266da
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Infections and cancer
|x 0
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ANN ONCOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ANN ONCOL : 2017
920 1 _ |0 I:(DE-He78)F022-20160331
|k F022
|l Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Infektionen und Krebs-Epidemiologie
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F022-20160331
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21